chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Headache; This is a spontaneous report from a contactable consumer, the patient. A male patient of unspecified age received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL2747), via unspecified route of administration in left arm on 16Mar2021 at 14:45 hours as a single dose for COVID-19 immunisation. Patient previously received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EL2747) via unspecified route of administration in left arm on 25Feb2021 at 13:45 hours for COVID-19 immunisation. Medical history was not reported. Patient had no allergies to medications, food, or other products. Prior to vaccination, the patient was not diagnosed with COVID-19 and since the vaccination, the patient had not been tested for COVID-19. Concomitant medications included sertraline (MANUFACTURER UNKNOWN) and LIPITOR. On 17Mar2021 at 16:00 hours, the patient experienced headache. Therapeutic measures taken as a result of event headache included self-treatment with Ibuprofen from an unknown date. The clinical outcome of reported event headache was resolving.   No follow-up attempts are possible. No further information is expected.
Headache; Low grade fever; This is a spontaneous report from a non-contactable consumer, the patient. An adult non-pregnant female received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6208) via an unspecified route of administration in the right arm on 17Mar2021 at 13:00 as a single dose for COVID-19 immunisation. Medical history included asthma. The patient was allergic to unspecified different medications. The patient had received unspecified medication within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 17Mar2021 at 14:15, the patient experienced headache and low grade fever. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event headache and low grade fever was resolved on an unknown date in 2021.     No follow-up attempts are needed. No further information is expected.
Fever, chills, body aches, sore & swelling at site Narrative: Employee developed fever 100.4, body aches, chills , sore at site with some swelling. Employee also has underlying immunodeficiency and advised to follow up with provider.
Given vaccine Thursday afternoon and by Friday morning had swelling, redness, and heat at injection site. Patient had aches over entire body and a headaches for 3 days.
This spontaneous report was received from an adult female medical assistant, reporting on herself. There was no information regarding the patient's pertinent medical history, drug reactions, allergies or concomitant therapies provided. On 24-MAR-2017, the patient was vaccinated with an expired dose of VAQTA 25/0.5 (unit not provided) injection (lot # L045713, expiration date 14-JAN-2017, 0.5 ml; site and route of administration were not provided). The medical assistant also reported that the expired dose of VAQTA was a pediatric dose, rather than an adult dose. No adverse effects were reported. Additional information has been requested.
PT did not have a reaction to this. The vaccine given was beyond use of refrigeration although lot number was not expired yet.
This case was reported by a physician and described the occurrence of body weakness in a female subject of unspecified age who was vaccinated with ENGERIX B (GlaxoSmithKline). On an unspecified date the subject received unspecified dose of ENGERIX B (unknown). At an unspecified time after vaccination with ENGERIX B, the subject experienced body weakness (weakness on one side of the body), eye pressure (pressure in the left eye) and blurred vision. At the time of reporting the outcome of the events was unspecified.
Onset of pain & weakness rt arm & hand /win a few hrs of IM administration. "stroke R/O by neurologist"
Swollen lymph nodes on left collarbone; This is a spontaneous report from a non-contactable consumer or other non hcp (patient). A 44-years-old female (non pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number: EL3249 and expiration date was not reported), via an unspecified route of administration, administered in Left Arm on 12Feb2021 (Age at vaccination was 44 years) as dose 2 single for COVID-19 immunization. The patient medical history was not reported. The patient did not have known allergies and other medical history were none. The patient did not have COVID prior to vaccination. Concomitant medication(s) included bupropion hydrochloride; ibuprofen; melatonin all taken for an unspecified indication, start and stop date were not reported. Previously patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, lot number EL9263 and expiration date was not reported), via an unspecified route of administration, administered in Left Arm on 22Jan2021 at 18:00 (at the age of 44 years ) hours as dose 1, single for COVID-19 immunization. The patient did not take any other vaccine in four weeks. On 16Feb2021 the patient experienced swollen lymph nodes on left collarbone. The patient was not tested covid after the vaccination. The patient did not receive the treatment. The outcome of the event was not recovered.  No follow-up attempts needed. No further information expected.
-delayed injection site redness/mild rash, appeared on 4/9/2021 and went away ~2 days later
Shingles; Cold sores; Fatigue; Shooting nerve pain from the corner of my eye to just below my nose; Shooting nerve pain from the corner of my eye to just below my nose/ pain; Just blow my nose I developed a Red blister/ blister; Just blow my nose I developed a Red blister/ blister; Tingling; This case was reported by a consumer via call center representative and described the occurrence of shingles in a female patient who received Herpes zoster (Shingrix) for prophylaxis.   The patient's past medical history included cold sores.   In August 2019, the patient received the 1st dose of Shingrix. On an unknown date, less than a month after receiving Shingrix, the patient experienced shingles, cold sores, fatigue, nerve pain, shooting pain, blister, localized erythema and tingling. The patient was treated with acyclovir. On an unknown date, the outcome of the shingles, cold sores, fatigue, nerve pain, shooting pain, blister, localized erythema and tingling were unknown.   The reporter considered the shingles, cold sores, nerve pain, shooting pain, blister, localized erythema and tingling to be unrelated to Shingrix. The reporter considered the fatigue to be related to Shingrix.  Additional details were provided as follows: The age at vaccination was not reported. The patient reported that, she received her 1st dose of Shingrix in the mid August 2019. The patient had expected fatigue reaction, but in addition she developed a shooting nerve pain from the corner of eye to just below her nose and just below nose she developed a red blister. She then quickly took acyclovir which had been prescribed for a cold sore and it went away. The patient enquired hat, whether she should take acyclovir prophylactically before receiving 2nd Shingrix dose. The patient further stated, this reaction was not listed anywhere and since Shingrix was not a live vaccine, she did not understand how she could have a case of shingles, since there was no denying that she had tingling, pain or blister. To answer patient's question, the call center representative provided information that, Shingrix does not contain any live virus, so it can not cause Shingles. Also there were no known interactions between Shingrix and acyclovir. The patient then asked, could Shingrix cause an outbreak of oral herpes in a new location, might be just from whacking the immune system but the call center representative denied it by explaining her that, shingles and herpes are two different infections caused by two different viruses. Shingles is caused by the varicella zoster virus (VZV), the same virus that causes chickenpox. Herpes is caused by the herpes simplex virus.
Information has been received from a physician concerning a 18 year old female patient with a history of liver injury who on 21-NOV-2011, was vaccinated with the first dose of GARDASIL. On 27-NOV-2011 (reported as "6 days following her initial dose"), the patient developed loss of hair. It was also reported that the patient was referred to an unspecified dermatologist for the hair loss, and was told that the cause of the hair loss might have been due to liver injury suffered by the patient 3 months before the administration of GARDASIL. The patient called office for medical attention. At the time of the report the patient's outcome was not recovered. Follow up information has been received from a nurse practitioner concerning an 18 year old female patient with no illness at time of vaccination and with no known drug allergies and significant health problems who on 21-NOV-2011 at 15.53 pm, was vaccinated intramuscularly with the first dose of GARDASIL, in left deltoid, (dose not reported) (lot number: 668554/0306AA). It was reported that patient's hair was falling out by the handfuls and she was beginning to have bald spots. Worsened over a few weeks, but finally it stopped and now had new hair growth. It was also reported that the patient was seen by dermatologist. At the time of the report the patient's outcome was recovered. It was reported that the patient's hair loss required medical/surgical intervention by the reporter. Additional information has been requested.
I experienced abdominal pain and felt unwell, and I also started to feel dizzy and fainted while sitting on a counter stool. I called my daughter to come help me get up but still felt disoriented. At 11PM at night, I also had trouble going to urine. I did take omeprazole medication. I do not know what caused my symptoms. My psychologist also evaluated and told me I had emotion stress and had digestive issues. I have not recovered from my symptoms. I feel since the COVID-19 pandemic my daily life activities.
Severe headache; This spontaneous case was reported by a consumer and describes the occurrence of HEADACHE (Severe headache) in a 57-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 030L20A and 025L20A) for COVID-19 vaccination.     Concurrent medical conditions included Migraine. Concomitant products included TRAMADOL and SUMATRIPTAN for Migraine, POTASSIUM, MULTIVITAMIN [VITAMINS NOS], MAGNESIUM and MOMETASONA [MOMETASONE] for an unknown indication.   On 21-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 28-Jan-2021, the patient experienced HEADACHE (Severe headache). At the time of the report, HEADACHE (Severe headache) outcome was unknown.            This case was linked to US-MODERNATX, INC.-MOD-2021-076700 (E2B Linked Report).; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-076700:MOD-2021-076700 Case for dose 1
This spontaneous report as received from a medical assistant refers to an unspecified number of patients of unknown age and gender. There was no information about the patients' concurrent conditions, concomitant therapies or medical histories provided. On 29-AUG-2016, the patients were vaccinated with improperly stored doses of ROTATEQ lot # L013204, expiration date 28-JAN-2017, oral (dose was not reported). There was no adverse effect reported. Administered doses of vaccines experienced the temperature excursion of 25 degrees Fahrenheit for 7 hours. This is one of several reports received from the same reporter. Additional information has been requested.
I am in a satellite clinic of the local Memorial group and receive the Covid vaccinations every other Wednesday from the local clinic for that day's vaccination clinic. On this day I had 1 pt scheduled for a first time Covid vaccine and received 1 bottle of monovalent Moderna. This patient came in requesting vaccination. We discussed we didn't have the multivalent vaccine and shared the information we received from the local clinic that we didn't know when we would receive it. The pt decided to receive the booster dose of monovalent Moderna and then wait for the multivalent dose when it was available. After the dose was administered we were made aware that the multivalent dose was available but not sent to us.
Following 1st dose of vax experienced pain @ inject site; Following 2nd dose of vax experienced prolonged pain & tenderness @ inject site;
Moderna COVID-19 Vaccine EUA.   I have a large raised, red itchy patch that is warm to the touch in the location on my left arm where the vaccine was injected.
Pt had allergic rxn to immunizations (Pediarix, HIB, Prevnar), swollen, red eyes, small blotchy redness to cheeks, forehead shots given at 1700, rxn noted at 17:30, Benadryl 8 mg PO given 17:50, by 18:30 rx decreased, swelling decreased, redness decreased, only slightly red around eyes, no resp distress noted.
It was reported that a 2 month old male pt received IPOL vaccination on 18-JAN-2001. On 31-JAN-2001 the pt died. No specifics were provided. Further information is requested. COD as per autopsy report was asphyxia due to aspiration of foreign object
Diarrhea; Fever 100.2F; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea) and PYREXIA (Fever 100.2F) in a 76-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 006B21A) for COVID-19 vaccination.     The patient's past medical history included Surgery (Gall Bladder removed years ago so when she eats greasy food, she gets Diarrhea.).   On 11-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 08-Apr-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 2 dosage form. On 09-Apr-2021, the patient experienced DIARRHOEA (Diarrhea) and PYREXIA (Fever 100.2F). At the time of the report, DIARRHOEA (Diarrhea) and PYREXIA (Fever 100.2F) had not resolved.
Injection site pain; Tiredness; Headache; Nausea; Swollen lymph nodes; This is a spontaneous report from a contactable consumer reported for herself. This 34-year-old female patient (not pregnant) received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 12Jan2021 08:45 AM on Arm right at single dose for covid-19 immunisation. Medical history included Achondroplasia. No allergies to medications, food, or other products. Concomitant medications included drospirenone, ethinylestradiol betadex clathrate (YAZ). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE) on 21Dec2020 09:00 AM on Arm right at single dose (Lot EH 9899) for covid-19 immunisation and experienced injection site pain, tiredness, headache, muscle pain, chills, joint pain, injection site swelling, injection site redness, nausea, feeling unwell on 21Dec2020. With second injection: injection site pain, tiredness, headache, nausea, swollen lymph nodes. Outcome of the events was unknown.  Information on the lot/batch number has been requested.
This spontaneous report as received from a medical assistant refers to a 4 year old patient of unknown gender. Information regarding concomitant medication, medical history and drug reactions/allergies was not reported. On 30-SEP-2016, the patient received improperly stored doses of PROQUAD (lot # M010478 with expiration date 01-SEP-2017, therapy type HSA; dose, route of administration and anatomical location were not reported). It was reported that the PROQUAD was improperly stored at -3.5 Celsius for 1 hour and 6 minutes. There was no previous temperature excursion. Data logger was involved. No symptoms were reported. This is one of several reports received from the same reporter. Additional information is not expected as all relevant information has been received. Sender's Comments: US-009507513-1610USA011245:
This spontaneous report as received from a physician refers to a patient of unknown age and gender. On 22-MAR-2013 at 11:20 am, the patient was vaccinated with VAQTA (lot # 0273AE and expiration date 06-DEC-2014) (dose, therapy route and anatomical location unspecified). The physician reported that VAQTA was exposed to multiple low temperature excursions. Excursion time -1: 157.50 hours (also reported 17 hours, 443 hours, 2, -5.4 hours, 60 hours, 2 admin). The patient was not experiencing any known symptoms. This is one of several reports from the same source. Additional information has been requested.
Vomiting x 1. Fever of 101. Swelling of (L) deltoid.
2-5-08. 1:30pm Call from "patient" saying he is itching "all over" since he started taking Oral Typhoid. He took 1 pill on 1/30, 2/1, and 2/3. Says he has no visible rash today but he did have last night. Recommended to contact his physician how and to not take any further medicine until he consults with Dr. He said he didn't want to contact his Dr. I again stressed the importance of not continuing his medication and contacting hid Dr.
Extremely reactive/swollen lymph nodes in both armpits and behind ear (possibly in other lymph nodes in body) that have not subsided in 6 months. Bloodwork, ultrasounds, mammogram, and biopsy. No other known symptoms. Still waiting on results of biopsy.
Five minutes after Hep A injection, child became pale, clammy and passed out. He was wheezing on exam. Rx 97% Epinephrine 0.3 ml, SC, given and albuterol aerosol was administered. Child recovered, wheezing disappeared. BP 86/50; Pulse Ox was 95%.
Local redness, color and swelling at left deltoid, cellulitis vs local immunization reaction.
Swollen throat, not able to swollow or breath Chili?s dizziness , shaking, coughing , feeling like being choked  Epipen, benedryl howpitalization
Started coughing terribly. I coughed so much that my stomach muscles hurt so bad. Just coughing, constantly. I used steam and tried to bring it up - very congested in my chest. Forced me to cough and couldn't sleep. Slept seated so I wouldn't cough as much. I took some cough syrup but didn't help. Extra vitamin C. Zicam. I felt so bad and went to ER.  Diagnosed with RSV. About 4 days later I went to Urgent Care, and they gave me an inhaler - and that helped. About 6 times a day, I would put my head over the steam to help the congestion. Still having a lot of coughing in early January but still able to walk for pleasure. Went back to Urgent Care when I returned home and got an X-ray, and all was clear. For 5 days, I took steroid Prednisone. A week later still coughing and residual irritation from congestion. Urgent Care once again and got another antibiotic. As of today, I still have some coughing.
At time of shot - pain in arm, syncope. Within hours - headache, fatigue,  nausea, pain in arm with movement. Next morning - increased nausea, fevers, pain in arm - cannot lift her arm.
I have had COVID Arm for five weeks and ibuprofen is not giving me any relief for the pain in my arm, shoulder, neck and armpit
Started having very heavy periods. I had a period that lasted 21 days, stopped for 4 days, and then started again. Ultrasound showed abnormal uterine growth. Surgery on 9/19/22 to remove growth and biopsy, and uterine ablation was completed at same time. Growth was benign.
Very Mild soreness at injection site; chills; mild achiness in muscles and joints; fatigue; very mild nausea All for about 24 hours
On December 25th I had mild chest pain and then on January 1st, 2021 I had severe chest pain that persisted and on January 3rd I was admitted into the hospital.  My Ddimer was elevated and my Troponin levels were elevated.  An angiogram was performed and Dr. injected nitro into my arteries because they were constricted from Coronary Spasms.
pt mom states pt came home & went directly to bed w/severe h/a, fever & chills;mom called PMD re: h/a-PMD states told mom to bring pt in to be seen if h/a cont;MD felt pt probably did not have adverse rxn to vax;c/o sick stomach;poss virus
This spontaneous report as received from a certified medical assistant refers to a patient of unknown age and gender. On 14-OCT-2014 the patient was vaccinated with PROQUAD (0.5 ml, subcutaneous, lot # K005195, expiry date: 10-OCT-2015) which underwent a temperature excursion prior to being administered. No adverse effects reported. This is one of several reports from the same reporter. Additional information has been requested.
patient received 1 dose of coronavirus vacccine in January. He was admitted to the hospital on 7/2/2001 with signs of acute hypoxic respiratory failure on 2 L of oxygen, with nasal pharyngeal swab PCR positive for coronavirus.
This spontaneous report was received from a certified medical assistant and refers to a patient of an unknown age and gender. The patient's pertinent medical history, concomitant medications and drug reactions or allergies were not reported. On 14-SEP-2018, the patient was vaccinated with a dose of VAQTA lot# N020503, which expired on 04-SEP-2018 (exact dose, frequency, site and route of administration were not reported). No adverse effect was reported.
pt recvd vax MAY92 & 5 hrs following vax exp severe h/a; treated w/ASA w/o relief; h/a lasted 2 hrs;
shrill, unusual, constant crying for 3 hrs, fever; pt given APAP;
Pt received Moderna vaccine on 12/30/20 at 10:08 am. At 10:17 am monitor flagged down nurse to check on pt. Pt was upright sitting in drivers seat of his truck with his eyes open and head/neck tilted back. Pt. was not responsive to shaking, sternal rub and/or calling his name to see if he could hear nurse for approximately 20-30 seconds. At that point pt. became alert and responsive. Pt was disorientated for a couple of seconds then realized what had happened. Pt stated that he felt light headed and was diaphoretic. Pt did not eat breakfast so was given a granola bar and water.
No adverse event; Patient had received expired vaccine yesterday; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine yesterday) and NO ADVERSE EVENT (No adverse event) in a 25-year-old patient of an unknown gender who received mRNA-1273 (Spikevax) (batch no. 057A22A) for COVID-19 prophylaxis.     No Medical History information was reported.    On 02-Apr-2023, the patient received first dose of mRNA-1273 (Spikevax) (unknown route) 1 dosage form. On 02-Apr-2023, the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine yesterday). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine yesterday) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 (Spikevax) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient had received expired vaccine yesterday).    No concomitant medications were provided. It was reported that vaccine was expired on 6-Feb-2023 and they caught it on 03-Apr-2023 because vaccine was administered yesterday. No treatment medication was provided.